These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16567036)

  • 61. Ischemic optic neuropathy in male veterans prescribed phosphodiesterase-5 inhibitors.
    Margo CE; French DD
    Am J Ophthalmol; 2007 Mar; 143(3):538-9. PubMed ID: 17317413
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction.
    Salem EA; Kendirci M; Hellstrom WJ
    Curr Opin Investig Drugs; 2006 Jul; 7(7):661-9. PubMed ID: 16869121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality].
    MMW Fortschr Med; 2003 Mar; 145(11):56-7. PubMed ID: 12688198
    [No Abstract]   [Full Text] [Related]  

  • 64. Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction.
    Corbin JD; Francis SH
    J Androl; 2003; 24(6 Suppl):S38-41. PubMed ID: 14581493
    [No Abstract]   [Full Text] [Related]  

  • 65. Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule.
    Bunnage ME; Mathias JP; Wood A; Miller D; Street SD
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6033-6. PubMed ID: 18951784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems.
    Schwarz ER; Kapur V; Rodriguez J; Rastogi S; Rosanio S
    Int J Impot Res; 2007; 19(2):139-48. PubMed ID: 16761012
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.
    Yoo J; Thai KM; Kim DK; Lee JY; Park HJ
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4271-4. PubMed ID: 17553682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors for treatment of erectile dysfunction.
    Jiang W; Sui Z; Macielag MJ; Walsh SP; Fiordeliso JJ; Lanter JC; Guan J; Qiu Y; Kraft P; Bhattacharjee S; Craig E; Haynes-Johnson D; John TM; Clancy J
    J Med Chem; 2003 Jan; 46(3):441-4. PubMed ID: 12540243
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Phosphodiesterase inhibitors in clinical practice. The present and the future. Part II].
    Baksheev BI; Kolomiets NM
    Klin Med (Mosk); 2007; 85(4):4-11. PubMed ID: 17564028
    [TBL] [Abstract][Full Text] [Related]  

  • 70. JNJ-10280205 and JNJ-10287069: Novel PDE5 inhibitors as clinical candidates for erectile dysfunction.
    Qiu Y; Bhattacharjee S; Kraft P; Mathew John T; Haynes-Johnson D; Jiang W; Sui Z; Lundeen S
    Int J Impot Res; 2006; 18(5):477-83. PubMed ID: 16528290
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Roundtable discussion: tadalafil study group.
    Kloner RA; Brindis RG; Cheitlin MD; Kuritzky L; Miller TA; Padma-Nathan H; Rosen RC
    Am J Cardiol; 2003 Nov; 92(9A):58M-65M. PubMed ID: 14609624
    [No Abstract]   [Full Text] [Related]  

  • 72. Pharmacology of erectile dysfunction in man.
    Cirino G; Fusco F; Imbimbo C; Mirone V
    Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension.
    Deibert P; Bremer H; Roessle M; Kurz-Schmieg AK; Kreisel W
    Eur Respir J; 2007 Jan; 29(1):220-1. PubMed ID: 17197488
    [No Abstract]   [Full Text] [Related]  

  • 74. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex, the heart, and heart failure.
    Kiowski W; Brunner H; Schalcher C
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):256-8. PubMed ID: 16959762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A).
    Lines TC; Ono M
    Phytomedicine; 2006 Mar; 13(4):236-9. PubMed ID: 16492525
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [After taking the table, immediate sex? New potency pill allows more time for love life].
    MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357491
    [No Abstract]   [Full Text] [Related]  

  • 78. Acute angle-closure glaucoma following sildenafil citrate-aided sexual intercourse.
    Ramasamy B; Rowe F; Nayak H; Peckar C; Noonan C
    Acta Ophthalmol Scand; 2007 Mar; 85(2):229-30. PubMed ID: 17305747
    [No Abstract]   [Full Text] [Related]  

  • 79. An update on the PDE-5 inhibitors (PDE-5i).
    McCullough AR
    J Androl; 2003; 24(6 Suppl):S52-8. PubMed ID: 14581496
    [No Abstract]   [Full Text] [Related]  

  • 80. Erectile dysfunction and cardiovascular considerations: managing patients effectively with phosphodiesterase type 5 inhibitors.
    Hutter AM
    Clin Cardiol; 2004 Apr; 27(4 Suppl 1):I1-2. PubMed ID: 15115188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.